09-10-2025
What began as a tech-driven rally has started to broaden out. According to some on Wall Street, that should help power indexes like the S&P 500 even higher.
09-10-2025
The cost-of-living adjustment can’t keep up with the actual cost of living, as retirees’ costs climb.
09-10-2025
Novo Nordisk, the Danish drugmaker behind Ozempic and other weight-loss drugs, said it’s paying up to $5.2 billion to buy Akero Therapeutics, a biotech with a drug in a late-stage trial to treat a fatal liver disease.
09-10-2025
PepsiCo saw an earnings beat and an improved full-year outlook, even as beverage volumes in North America extended their long streak of declines.